Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 11 matching records.
11 results — page 1 of 1
- Level BClinical TrialPubMed
Safety and feasibility of intravenous fresh adipose-derived mesenchymal stem cells in secondary progressive multiple sclerosis: phase I/IIa clinical results.
Clinical Trial on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther1 citations - Level BClinical TrialEurope PMC
Consecutive intrabronchial administration of Wharton's jelly-derived mesenchymal stromal cells in ECMO-supported pediatric patients with end-stage interstitial lung disease: a safety and feasibility study (CIBA method)
Clinical Trial on Face & Skin, Systemic / IV, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther3 citations - Level BClinical TrialPubMed
Safety and Feasibility of Intradiscal Administration of Matrilin-3-Primed Adipose-Derived Mesenchymal Stromal Cell Spheroids for Chronic Discogenic Low Back Pain: Phase 1 Clinical Trial.
Clinical Trial on Back Pain, Disc Degeneration, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci11 citations - Level CProspective StudyPubMed
Low-dose mesenchymal stem cell therapy for discogenic pain: safety and efficacy results from a 1-year feasibility study.
Prospective Study on Back Pain, Disc Degeneration, published in Future Sci OA (2022) — summary generated from the PubMed abstract.
- 2022
Future Sci OA13 citations - Level BClinical TrialPubMed
Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized clinical trial, pha
Clinical Trial with a reported sample of 3 on Hair & Scalp, published in J Ovarian Res (2021) — summary generated from the PubMed abstract.
- 2021
- n = 3
J Ovarian Res59 citations - Level BClinical TrialPubMed
Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease.
Clinical Trial on Face & Skin, published in Ocul Surf (2020) — summary generated from the PubMed abstract.
- 2020
Ocul Surf54 citations - Level DAnimal StudyPubMed
Adipose tissue-derived mesenchymal stromal cells for treating chronic kidney disease: A pilot study assessing safety and clinical feasibility.
Animal Study on Chronic Kidney Disease, published in Kidney Res Clin Pract (2019) — summary generated from the PubMed abstract.
- 2019
Kidney Res Clin Pract - Level ASystematic ReviewEurope PMC
Safety and Feasibility of Repeated Intrathecal Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells in Patients with Neurological Diseases
Systematic Review with a reported sample of 37 on Back & Spine, published in Stem Cells Int (2019) — summary generated from the PubMed abstract.
- 2019
- n = 37
Stem Cells Int18 citations - Level CProspective StudyPubMed
Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study.
Prospective Study on Neuroinflammation, published in PLoS One (2018) — summary generated from the PubMed abstract.
- 2018
PLoS One119 citations - Level BClinical TrialPubMed
Systemic Infusion of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Peritoneal Dialysis Patients: Feasibility and Safety.
Clinical Trial on Chronic Kidney Disease, published in Cell J (2018) — summary generated from the PubMed abstract.
- 2018
Cell J22 citations - Level CProspective StudyPubMed
Human Adipose-Derived Mesenchymal Stem Cells in Cell Therapy: Safety and Feasibility in Different "Hospital Exemption" Clinical Applications.
Prospective Study with a reported sample of 17 on Chronic Wound, Immune Modulation, published in PLoS One (2015) — summary generated from the PubMed abstract.
- 2015
- n = 17
PLoS One61 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406